HighLife Medical
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $40M
Investors
- 6
About HighLife Medical
HighLife SAS is dedicated to advancing medical solutions, particularly focusing on treatments for mitral regurgitation using their pioneering HighLife TSMVR device. Founded in 2010 and headquartered in Paris, France, HighLife SAS specializes in the development of medical devices. The company has undergone strategic pivots to focus on its flagship HighLife TSMVR (Trans-septal Mitral Valve Replacement) solution for treating mitral regurgitation. The firm was founded by Georg Börtlein, Malek Nasr, Prof. Rüdiger Lange and Dr. Nicolo Piazza. HighLife Medical specializes in medical solutions, particularly focusing on the treatment of mitral regurgitation (MR) through its flagship product, the HighLife TSMVR (Trans-septal Mitral Valve Replacement) solution. This investigational device is designed to address the needs of patients suffering from moderate to severe MR, the most prevalent valvular heart condition globally. The TSMVR solution offers a transcatheter approach that aims to provide alternatives to traditional surgical methods. HighLife Medical primarily targets healthcare providers, including cardiologists and hospitals, across key geographical markets such as the United States and Europe, where the demand for innovative cardiovascular solutions is growing. Revenue generation is facilitated through business-to-business (B2B) transactions with healthcare institutions and specialized medical providers, focusing on the adoption of their advanced cardiac technologies. The revenue structure is based on the delivery of a medical device that addresses critical patient needs, aligning with healthcare providers' goals to improve treatment outcomes in patients with mitral regurgitation. HighLife SAS aims to expand its product line by developing new versions of the TSMVR device, with anticipated launches in upcoming years contingent on regulatory approvals. The company is also exploring expansion into new markets, including additional European countries and the Asia-Pacific region by 2024.
Who invested in HighLife Medical
6 investors across 3 rounds
See all investors in HighLife Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HighLife Medical
Who invested in HighLife Medical?
HighLife Medical has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HighLife Medical raised?
HighLife Medical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did HighLife Medical last raise money?
HighLife Medical's most recent round on record is a Series B, in Feb 2021.
What does HighLife Medical do?
HighLife SAS is dedicated to advancing medical solutions, particularly focusing on treatments for mitral regurgitation using their pioneering HighLife TSMVR device.
Where is HighLife Medical headquartered?
HighLife Medical is headquartered in Paris, France.
Which VCs invest in companies like HighLife Medical?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at HighLife Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like HighLife Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.